Detalhe da pesquisa
1.
The cyclophosphamide equivalent dose as an approach for quantifying alkylating agent exposure: a report from the Childhood Cancer Survivor Study.
Pediatr Blood Cancer
; 61(1): 53-67, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-23940101